Nowadays, the number of traditional Chinese medicine (TCM) guidelines is constantly increasing, but its reporting quality remains unsatisfactory. One of the main reasons is that there is a lack of suitable reporting standard to guide it. In response to this long-standing problem, the Reporting Items for practice Guidelines in HealThcare (RIGHT) Working Group has invited a group of TCM clinical experts, methodologists and epidemiology, and developed the RIGHT Extension Statement for TCM (RIGHT-TCM) through a multi-staged development process, including systematic review, reporting quality evaluation and online Delphi expert consensus. The RIGHT-TCM extends two sections of the RIGHT Statement, includes basic information and recommendations section. Seven strong recommendation sub-items were added to RIGHT Statement and formed the final RIGHT-TCM. The group hopes that the RIGHT-TCM may assist TCM guideline developers in reporting guidelines, support journal editors and peer reviewers when considering TCM guideline reports, and help health care practitioners understand and implement a TCM guideline. This article will introduce its background, development, recommendations and explanation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462769 | PMC |
| http://dx.doi.org/10.1016/j.phrs.2020.105178 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- - This study reviewed randomized controlled trials (RCTs) focusing on how traditional Chinese medicine (TCM) treats angina pectoris in coronary heart disease patients after percutaneous coronary intervention (PCI), analyzing various research design elements and outcomes.
- - A total of 188 RCTs were included, encompassing 15,521 patients, with variations in sample sizes and treatment groups that combined TCM with guideline-directed medical therapy (GDMT).
- - The study identified common TCM syndromes among patients and categorized numerous outcome indicators used to measure treatment effectiveness, pointing out that most trials lacked a defined follow-up period.
[Expert consensus on clinical application of Dieda Qili Tablets in treatment of acute soft tissue injury].
Zhongguo Zhong Yao Za Zhi
September 2024
Wangjing Hospital of China Academy of Chinese Medical Sciences Beijing 100102, China Beijing Key Laboratory of Orthopaedic Technology of Traditional Chinese Medicine Beijing 100102, China.
Dieda Qili Tablets are protected traditional Chinese medicine(TCM) variety and type B medicine included in medical insurance in China, which is widely used in the treatment of acute soft tissue injury in clinical practice and has been recommended by many books. However, there is no evidence-based guideline or consensus to guide the clinical application of Dieda Qili Tablets. With the support of China Association of Chinese Medicine, Wangjing Hospital of China Academy of Chinese Medical Sciences led the 21 Chinese units to follow the guiding ideology of "evidence as the key, consensus as the supplement, and experience as the reference" to compile this consensus.
View Article and Find Full Text PDF[Expert consensus on clinical application of Xiangshao Granules].
Zhongguo Zhong Yao Za Zhi
September 2024
Xiangshao Granules are widely used in clinical practice for the treatment of premenstrual tension syndrome and menopausal syndrome. However, at present, there is no evidence-based medicine guideline or consensus formed. In order to standardize the rational use of drugs by clinical physicians and maximize the value of Xiangshao Granules, this consensus is formulated.
View Article and Find Full Text PDF[Analysis of prescription rules for hyperlipidemia comorbid with hypertension based on latent structure model and association rules].
Zhongguo Zhong Yao Za Zhi
September 2024
Heart Center/National Regional (Traditional Chinese Medicine) Cardiovascular Diagnosis and Treatment Center, the First Affiliated Hospital of Henan University of Chinese Medicine Zhengzhou 450000, China.
Based on the latent structure model and association rule analysis, the regularity of prescription for hyperlipidemia comorbid with hypertension was explored, and traditional Chinese medicine(TCM) pattern type was speculated to provide a reference for clinical pattern differentiation and treatment, and guideline establishment. The literature on the treatment of hyperlipidemia comorbid with hypertension by TCM was systematically searched on CNKI, Wanfang, VIP, and SinoMed academic platforms. The relevant information was extracted and a database was established using Microsoft Excel 2019.
View Article and Find Full Text PDFAssociation Between Female Androgen Levels, Metabolic Syndrome, and Cardiovascular Disease: An NHANES Analysis (2013-2016).
Int J Womens Health
December 2024
Department of Obstetrics and Gynecology, Zhongda Hospital, Nanjing, Jiangsu, People's Republic of China.
Background: The impact of androgens on metabolic diseases, cardiovascular diseases (CVD), and long-term mortality in the general female population remains poorly understood. This study, utilizing data from the National Health and Nutrition Examination Survey (NHANES) database managed by the Centers for Disease Control and Prevention, seeks to elucidate the relationship between androgen levels and metabolic syndrome (MS), CVD, and mortality in adult women.
Methods: After excluding ineligible individuals, descriptive analyses were conducted on demographic characteristics, metabolic-related indicators, and disease prevalence, based on the presence of high androgenemia and androgen quartile grouping.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!